Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 30, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 1, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001639691-26-000026
Filed / recorded
Apr 1, 2026, 9:20 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
LivaNova PLC
Issuer CIK
1639691
Ticker
LIVN
Reporting person
Franco Poletti
Relationship
Officer
Officer title
President, Cardiopulmonary
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Mar 30, 2026
Transaction code
M
Shares / units
2,130
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
4,258
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.
On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement.